Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide,
and viral genes are expressed in the malignant cells. EBV also very efficiently causes the …

Epstein–Barr virus (EBV) is the first identified human oncogenic virus that can establish
asymptomatic life-long persistence. It is associated with a large spectrum of diseases …

Epstein-Barr virus (EBV) causes Burkitt, Hodgkin, and post-transplant B cell lymphomas.
How EBV remodels metabolic pathways to support rapid B cell outgrowth remains largely …

Abstract The Epstein–Barr virus (EBV) is epidemiologically associated with development of
autoimmune diseases, including systemic lupus erythematosus, Sjögren syndrome …

Super-enhancers are clusters of gene-regulatory sites bound by multiple transcription
factors that govern cell transcription, development, phenotype, and oncogenesis. By …

Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus which asymptomatically infects
the majority of the world population. Under immunocompromised conditions, EBV can …

Epstein-Barr virus nuclear antigen 2 (EBNA2) regulation of transcription through the cell
transcription factor RBPJ is essential for resting B-lymphocyte (RBL) conversion to immortal …

The transcription factor c‐Myc is a key regulator of cell proliferation, cell growth,
differentiation, and apoptosis. Deregulated c‐myc expression possesses a high …

Epstein-Barr virus (EBV) transforms B cells to continuously proliferating lymphoblastoid cell
lines (LCLs), which represent an experimental model for EBV-associated cancers. EBV …

Epstein-Barr virus (EBV) infection of human primary resting B lymphocytes (RBLs) leads to
the establishment of lymphoblastoid cell lines (LCLs) that can grow indefinitely in vitro. EBV …